THE SCHEDULE 13G

Company

AN2 Therapeutics, Inc.

Filed

April 4, 2022

Accession Number

0000921895-22-001065

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →